A PROSPECTIVE STUDY ON TESTICULAR MAPPING AND ITS CO-RELATION WITH SERUM HORMONAL LEVELS.
DOI:
https://doi.org/10.51168/sjhrafrica.v5i12.1499Keywords:
Azoospermia, Nonobstructive Azoospermia, Obstructive Azoospermia, Hormonal MarkersAbstract
Background
Azoospermia, the complete absence of sperm in the ejaculate, is a major cause of male infertility, affecting 1% of men globally. It is categorized into obstructive azoospermia (OA) and non-obstructive azoospermia (NOA), with NOA being more prevalent and presenting challenges for sperm retrieval. Despite advances in techniques like intracytoplasmic sperm injection (ICSI), reliable markers for successful sperm retrieval in NOA remain unclear.
Aims
This study aims to evaluate histopathological abnormalities in azoospermic males and assess the efficacy of testicular mapping for sperm retrieval. It also focuses on the diagnostic value of serum inhibin B and other hormones in distinguishing OA from NOA.
Methods
This was a prospective study involving 54 male patients diagnosed with azoospermia, assessed through a compound testicular mapping procedure with 14 microbiomes. Hormonal assessments such as follicular stimulating hormone (FSH), luteinizing hormone (LH), testosterone, and inhibin B were conducted before and after the biopsy. Histopathological analysis was focused on confirming azoospermia, differentiating OA from NOA, and identifying focal spermatogenesis. Statistical analysis correlates hormone levels with biopsy findings to evaluate diagnostic outcomes.
Results
The study analyzed 54 cases of azoospermia in men aged 20-39 years, with non-obstructive azoospermia (NOA) being more prevalent (74.1%) than Obstructive Azoospermia (OA) (25.9%). NOA cases were further classified into hypospermatogenesis, maturation arrest, and Sertoli cell-only syndrome. Hormonal analysis revealed significant differences in serum LH, FSH, testosterone, and inhibin B levels across azoospermia subtypes, with serum inhibin B showing the highest sensitivity and specificity for differentiating OA and NOA. The findings underscore hormonal variability and the potential of inhibin B as a clinical marker for azoospermia classification.
Conclusion
The study highlights significant hormonal differences between obstructive and nonobstructive azoospermia subtypes, with serum Inhibin B emerging as the most reliable marker for differentiation.
References
Tiseo BC, Hayden RP, Tanrikut C. Surgical management of nonobstructive azoospermia. Asian journal of urology. 2015 Apr 1;2(2):85-91. https://doi.org/10.1016/j.ajur.2015.04.020
Cocuzza M, Alvarenga C, Pagani R. The epidemiology and etiology of azoospermia. Clinics. 2013;68:15-26. https://doi.org/10.6061/clinics/2013(Sup01)03
Cioppi F, Rosta V, Krausz C. Genetics of azoospermia. International Journal of Molecular Sciences. 2021 Mar 23;22(6):3264. https://doi.org/10.3390/ijms22063264
Vasan SS. Azoospermia: Diagnosis and Management. Male Infertility: A Clinical Approach. 2017:85-106. https://doi.org/10.1007/978-81-322-3604-7_6
Aydos K, Aydos OS. Sperm selection procedures for optimizing the outcome of ICSI in patients with NOA. Journal of Clinical Medicine. 2021 Jun 18;10(12):2687. https://doi.org/10.3390/jcm10122687
Moskovtsev SI, Dviri M, Librach CL. Methods to Select Ejaculated, Epididymal, and Testicular Spermatozoa for Assisted Conception. Men's Reproductive and Sexual Health Throughout the Lifespan: An Integrated Approach to Fertility, Sexual Function, and Vitality. 2023 Nov 16;9:204. https://doi.org/10.1017/9781009197533.027
Palermo GD, Neri QV, Schlegel PN, Rosenwaks Z. Intracytoplasmic sperm injection (ICSI) in extreme cases of male infertility. PLoS One. 2014 Dec 1;9(12):e113671. https://doi.org/10.1371/journal.pone.0113671
Leung A, Mira J, Hsiao W. Updates on sperm retrieval techniques. Translational Andrology and Urology. 2014 Mar;3(1):94.
Shah R, Gupta C. Advances in sperm retrieval techniques in azoospermic men: A systematic review. Arab journal of urology. 2018 Mar 1;16(1):125-31. https://doi.org/10.1016/j.aju.2017.11.010
Janosek-Albright KJ, Schlegel PN, Dabaja AA. Testis sperm extraction. Asian journal of urology. 2015 Apr 1;2(2):79-84. https://doi.org/10.1016/j.ajur.2015.04.018
Guler I, Erdem ME, Erdem A, Demirdağ E, Tunc L, Bozkurt N, Mutlu MF, Oktem M. Impact of testicular histopathology as a predictor of sperm retrieval and pregnancy outcome in patients with nonobstructive azoospermia: correlation with clinical and hormonal factors. Andrologia. 2016 Sep;48(7):765-73. https://doi.org/10.1111/and.12510
Genesis L, Scarselli F, Minasi MG, Mariani S, Lubrano C, Basciani S, Greco PF, Watanabe M, Franco G, Farcomeni A, Greco E. Testicular histopathology, semen analysis and FSH, predictive value of sperm retrieval: supportive counseling in case of reoperation after testicular sperm extraction (TESE). BMC urology. 2018 Dec;18:1-8. https://doi.org/10.1186/s12894-018-0379-7
Negri F, Boeri L, Cilio S, Pozzi E, Belladelli F, Corsini C, Raffo M, Fallara G, Ventimiglia E, Candela L, d'Arma A. The Importance of Discordant Follicle Stimulating Hormone and Inhibin B Levels in Primary Infertile Men: Findings from a Cross-Sectional Study. The World Journal of Men's Health. 2024 Jan 2;42. https://doi.org/10.5534/wjmh.230298
Kong X, Ye Z, Chen Y, Zhao H, Tu J, Meng T, Xiong C, Li H, Gong Y, Zheng L, Cheng B. Clinical application value of Inhibin B alone or in combination with other hormone indicators in subfertile men with different spermatogenesis status: A study of 324 Chinese men. Journal of Clinical Laboratory Analysis. 2021 Aug;35(8):e23882. https://doi.org/10.1002/jcla.23882
Pozzi E, Corsini C, Belladelli F, Bertini A, Negri F, Raffo M, Saccà A, Ventimiglia E, Boeri L, Fallara G, d'Arma A. Role of Follicle-stimulating Hormone, Inhibin B, and Anti-Müllerian Hormone in Predicting Sperm Retrieval from Men with Nonobstructive Azoospermia Undergoing Microdissection Testicular Sperm Extraction: A Systematic Review and Meta-analysis. European Urology Open Science. 2024 Jul 1;65:3-12. https://doi.org/10.1016/j.euros.2024.05.001
Tang WH, Zhou SJ, Song SD, He HY, Wu H, Zhang Z, Yang YZ, Zhang HL, Mao JM, Liu DF, Zhao LM. A clinical trial on the consistency of bilateral testicular tissue histopathology and Johnsen score: single side or bilateral side biopsy? Oncotarget. 2018 May 5;9(35):23848. https://doi.org/10.18632/oncotarget.24748
Andrade DL, Viana MC, Esteves SC. Differential diagnosis of azoospermia in men with infertility. Journal of Clinical Medicine. 2021 Jul 16;10(14):3144. https://doi.org/10.3390/jcm10143144
Huang IS, Huang WJ, Lin AT. Distinguishing non-obstructive azoospermia from obstructive azoospermia in Taiwanese patients by hormone profile and testis size. Journal of the Chinese Medical Association. 2018 Jun 1;81(6):531-5. https://doi.org/10.1016/j.jcma.2017.09.009
Kong X, Ye Z, Chen Y, Zhao H, Tu J, Meng T, Xiong C, Li H, Gong Y, Zheng L, Cheng B. Clinical application value of Inhibin B alone or in combination with other hormone indicators in subfertile men with different spermatogenesis status: A study of 324 Chinese men. Journal of Clinical Laboratory Analysis. 2021 Aug;35(8):e23882. https://doi.org/10.1002/jcla.23882
Von Eckardstein S, Simoni M, Bergmann M, Weinbauer GF, Gassner P, Schepers AG, Nieschlag E. Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men. Still, it cannot predict the presence of sperm in testicular tissue samples. The Journal of Clinical Endocrinology & Metabolism. 1999 Jul 1;84(7):2496-501. https://doi.org/10.1210/jcem.84.7.5855
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Piyush Agarwal, Kshirabdhi Tanaya Panda, Vishal Neniwal, Suresh Kumar Rulaniya, D.Hota
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
